[The use of diksafen for curing the neurotoxic reactions of cancer patients undergoing radiation and chemotherapy].
The paper discusses a clinical trial of a newly developed Soviet preparation--dixaphen which was administered to 40 patients who had received radiation and chemotherapy for Hodgkin's disease and tumors at other sites. A single intramuscular injection of 1.0 ml was found to abort emesis in 80-90% and asthenic syndrome--in 60-75%. The drug was well tolerated; it is recommended for treatment of malignant tumors.